Doctor Anywhere Raises US$65.7M in Series C Financing
Summary
As a result of the financing, Dr Amit Kakar, Senior Partner, Head of Novo Holdings Equity Asia will join Doctor Anywhere’s Board of Directors and Carol Wang, Senior Associate, Novo Holdings Equity Asia will join the Board as an Observer. Led by Lim Wai Mun, Founder and Chief Executive Officer, Doctor Anywhere combines technology and innovation to provide a digital platform that enables patients to access medical assistance on-demand anytime, without leaving their homes, whilst its offline platform provides users with access to resources such as GP clinics and mobile healthcare services. The company’s services allow for the management of a wide range of acute and chronic conditions in both adults and children, such as home-based health screenings and vaccinations, medication access and distribution, COVID-19 testing, mental wellness support, and nutrition and fitness counselling. Since its launch in 2017, Doctor Anywhere has grown to serve more than 1.5 million users in Singapore and the wider region. The group also recently announced the establishment of regional tech hubs in Bangalore, India, and Ho Chi Minh City, Vietnam.
Funding
Review available funding amount, funding date, investors, and linked company information related to Doctor Anywhere Raises US$65.7M in Series C Financing in the interactive ISVWorld profile.